Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 14;103(24):e37963.
doi: 10.1097/MD.0000000000037963.

Global research landscape and emerging trends in Graves' disease: A bibliometric analysis

Affiliations

Global research landscape and emerging trends in Graves' disease: A bibliometric analysis

Yan Yang et al. Medicine (Baltimore). .

Abstract

Background: Graves' disease is a prevalent thyroid disorder and is the primary cause of hyperthyroidism. Significant progress has been made in understanding the epidemiology, pathogenesis, diagnosis, treatment, and prognosis of this disease. However, bibliometric analyses on Graves' disease are lacking. We aimed to comprehensively summarize the research, progression, and focal points of Graves' disease through data mining and integrated analysis of the existing literature.

Methods: We retrieved relevant literature on Graves' disease from 2003 to 2023 from the Web of Science database. We performed bibliometric analysis using CiteSpace and the R package Bibliometrix.

Results: We identified 10,901 publications from 132 countries, with a steady rise in the number of publications over the past 5 years. The US leads in publication volume, with the University of California System being the primary contributing institution. The journal Thyroid had the highest publication output, while the Journal of Clinical Endocrinology and Metabolism was the most frequently cited. These publications involved 2305 authors, with Antonelli Alessandro and Smith Terry being the most prolific. The most frequently cited articles were the "2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis" and the "Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy." Analysis of the bursts of cited references, keywords, and their clustering revealed that research on Graves' disease predominantly centers on clinical management, thyroid-stimulating hormone receptors, thyroid hormones, autoimmunity and inflammation, Graves' ophthalmopathy, thyroid nodules, and thyroid cancer.

Conclusion: This is the first comprehensive bibliometric study to summarize progress and trends in Graves' disease research. These results highlight recent research hotspots and promising directions, thereby providing a valuable reference for other scholars.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Flowchart of the publication screening process.
Figure 2.
Figure 2.
Annual output of publications.
Figure 3.
Figure 3.
Geographic distribution (A) and visualization (B) of countries where GD research has been conducted.
Figure 4.
Figure 4.
Visualization of institutions on GD research.
Figure 5.
Figure 5.
Visualization of co-cited journals on GD research.
Figure 6.
Figure 6.
Dual-map overlay of journals on GD research.
Figure 7.
Figure 7.
Visualization of authors (A) and co-cited authors (B) who have performed GD research.
Figure 8.
Figure 8.
Visualization of co-cited references on GD research.
Figure 9.
Figure 9.
Top 20 references with strong citation bursts.
Figure 10.
Figure 10.
Top 50 keywords with strong citation bursts.
Figure 11.
Figure 11.
Visualization of the analysis of keywords (A) and keyword clusters (B) on GD research.

Similar articles

References

    1. Wémeau JL, Klein M, Sadoul JL, Briet C, Vélayoudom-Céphise FL. Graves’ disease: introduction, epidemiology, endogenous and environmental pathogenic factors. Ann Endocrinol (Paris). 2018;79:599–607. - PubMed
    1. Antonelli A, Fallahi P, Elia G, et al. . Graves’ disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020;34:101388. - PubMed
    1. Lane LC, Wood CL, Cheetham T. Graves’ disease: moving forwards. Arch Dis Child. 2023;108:276–81. - PMC - PubMed
    1. Antonelli A, Ferrari SM, Ragusa F, et al. . Graves’ disease: epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34:101387. - PubMed
    1. Vejrazkova D, Vcelak J, Vaclavikova E, et al. . Genetic predictors of the development and recurrence of Graves’ disease. Physiol Res. 2018;67(Suppl 3):S431–9. - PubMed